Discovery and Characterization of Vicriviroc (SCH 417690), a CCR5 Antagonist with Potent Activity against Human Immunodeficiency Virus Type 1 Julie M. Strizki,Cecile Tremblay,et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY Dec. 2005;49:4911–4919
Vicriviroc Is a Novel, Potent CCR5 Inhibitor With Outstanding Pharmaceutic, Pharmacokinetic and PharmaCodynamic (PK/PD) Properties Lisa Dunkle, Anther Keung,et al. Retrovirology 2005;2(Suppl 1):S12
Vicriviroc, A Novel CCR5 Inhibitor, is NOT A p-glycoprotein Substrate In Vitro Cheng Li,Anther Keung,et al. Retrovirology 2005;2(Suppl 1):P158
The pharmacological and toxicological properties of this product have not been fully investigated. Exercise caution in use and handling. This product must not be used in humans.